RT Journal Article
SR Electronic
T1 Quantifying operator subjectivity within Flow Cytometry Data Analysis as a source of measurement uncertainty and the impact of experience on results
JF PDA Journal of Pharmaceutical Science and Technology
JO PDA J Pharm Sci Technol
FD Parenteral Drug Association (PDA)
SP pdajpst.2019.011213
DO 10.5731/pdajpst.2019.011213
A1 Rebecca Grant
A1 Karen Coopman
A1 Nicholas Medcalf
A1 Sandro Silva-Gomes
A1 Bo Kara
A1 Jonathan J Campbell
A1 Julian Braybrook
A1 Jon Petzing
YR 2020
UL http://journal.pda.org/content/early/2020/10/16/pdajpst.2019.011213.abstract
AB Background: Flow Cytometry is a complex measurement characterisation technique, utilised within the manufacture, measurement and release of Cell and Gene Therapy products for rapid, high content and multiplexed discriminatory cell analysis. A number of factors influence the variability in the measurement reported including, but not limited to, biological variation, reagent variation, laser and optical configurations and data analysis methods. This research focuses on understanding the contribution of manual operator variability within the data analysis phase. Methods: 38 participants completed a questionnaire providing information about experience and motivational factors, before completing a simple gating study. Results were analysed using Gauge Repeatability & Reproducibility techniques to quantify participant uncertainty. The various stages of the gating sequence were combined through summation in quadrature and expanded to give each participant a representative uncertainty value. Results: 85 % of participants surveyed preferred manual gating to automated data analysis, with primary reasons being legacy (″it′s always been done that way″) and accuracy, not in the metrological sense, but in clear definition of the correct target population. The median expanded uncertainty was calculated as 3.6 % for the population studied, with no significant difference between more or less experienced users. Discussion: Operator subjectivity can be quantified to include within measurement uncertainty budgets, required for various standards and qualifications. An emphasis on biomanufacturing measurement terminology is needed to help understand future and potential solutions, possibly looking at translational clinical models to engage and enhance better training and protocols within industrial and research settings.